[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS [FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
摘要:
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).
[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS [FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
摘要:
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).
An I2-promoted formal [3+2] cycloaddition for access to oxazoles has been demonstrated. This is the first example of a Lewis acid-promoted formal [3+2] cycloaddition of isocyanides with methyl ketones involves...
Silver‐Induced [3+2] Cycloaddition of Isocyanides with Acyl Chlorides: Regioselective Synthesis of 2,5‐Disubstituted Oxazoles
作者:Jian‐Quan Liu、Xuanyu Shen、Andrey Shatskiy、Enlong Zhou、Markus D. Kärkäs、Xiang‐Shan Wang
DOI:10.1002/cctc.201900965
日期:2019.9.5
A silver‐induced cycloaddition of isocyanides with acyl chlorides has been developed. This transition metal‐catalyzed strategy provides an effective and scalable approach for the formation of 2,5‐disubstituted oxazoles in good to high yields. The employed silver‐based MOF catalyst can be efficiently recycled without compromising the yield.
The invention provides antimicrobial agents and methods of using the agents for sterilization, sanitation, antisepsis, disinfection, and treatment of infections in mammals.
这项发明提供了抗微生物药剂及其使用方法,用于哺乳动物的消毒、卫生、防腐、消毒和治疗感染。
[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS<br/>[FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
申请人:[en]MISSION THERAPEUTICS LIMITED
公开号:WO2023099561A1
公开(公告)日:2023-06-08
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).